This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we spend time with Josh Soldo, the Chief Scientific Officer at Veravas, and a healthcare innovator dedicated to developing diagnostic tests that enhance patient survival rates and reduce preventable medical tragedies.  While together, Josh shares his personal and professional journey to entrepreneurship and why he is on a mission to revolutionize healthcare and improve patient care. We explore his deep industry expertise, the importance of networking, Veravas' exciting ventures, his company’s strategic business model pivot, and Josh's vision for the industry's future. Join us to learn from Josh how he and the Veravas team are saving lives by transforming laboratory medicine! Let’s go! Episode Highlights:Josh’s deep industry experience that prepared him to help lead VeravasWhy networking is important to help discover new career opportunitiesWhat Josh and the Veravas team are most excited aboutHow Veravas pivoted their business model to meet market needsWhere Josh sees the industry heading over the coming years  About our Guest: Josh Soldo is a healthcare innovator who has dedicated his career to developing diagnostic tests with the mission of giving patients a greater chance of survival and reducing the number of preventable medical tragedies. He has over 25 years of experience in diagnostic technology, product development, and commercialization in the life sciences industry, and he is a subject matter expert in solid phase chemistry, sample interference, and Vitamin D testing. He is a sought-after speaker and educator, and his research and patent portfolio include six granted US patents and over 50 international patents. His expertise in assay development and solid phase chemistry has been instrumental in his invention of Veravas' proprietary magnetic bead technology for sample interference elimination and biomarker enrichment. Josh has held numerous R&D and Scientific Affairs leadership roles over the past 20 years at Roche, Anteo Technologies, DiaSorin, and Beckman Coulter. He received the 2017 Roche Career Achievement Award for demonstrating continued commitment and achievement of excellence within Medical & Scientific Affairs, and the 2006 Beckman Coulter “Innovation in Technology” corporate award for his research to improve the quality and manufacturing scale of the Access immunoassays. At DiaSorin his teams developed and commercialized the market-leading LIAISON 25 OH Vitamin D Total Assay, and he was the principal inventor of the world's first fully automated, extraction-free immunoassay for the accurate detection of 1,25 Dihydroxyvitamin D. Josh’s vision for Veravas is to continue leveraging its innovative VeraBIND technology platform to develop better diagnostics tools and treatments, ultimately improving patient care. Josh’s leadership is playing a significant role in the company’s success and has enabled Veravas to provide tools supporting the development of assays with unparalleled accuracy and sensitivity.Links Supporting This Episode:Veravas Website: CLICK HEREJosh Soldo LinkedIn page: CLICK HEREVeravas Twitter page: CLICK...

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we are joined by Helene Rutledge, President and Co-Founder of Mend, a revolutionary healing company that is transforming healthcare through Nutripharma-Powered Digital Wellness. While together, we discuss Helene’s extensive experience in the healthcare industry and her vision of leveraging personalized nutrition and digital support to make measurable impact on patient outcomes. Additionally, Helene takes us on the journey of Mend, from her background as a chemical engineer to the formation of the company. We also delve into Mend's offerings, including personalized regimens for different episodes of care and the incorporation of digital components for better surgical outcomes. Join us to discover how Helene and the Mend team are shaping the future of healthcare through personalized nutrition and digital support. Let’s go! Episode Highlights:Personalization of healthcare and leveraging individual backgrounds and expertiseJourney and formation of Mend, starting from Helene's career as a chemical engineerThe merger between Upgraid and Mend and the unique approach to clinical nutritionThe digital component of Mend's offerings and personalized regimens for different episodes of careWhat the patient feedback on the prevention of emergencies has been like  About our Guest: Helene Rutledge brings a career of experience in the Healthcare industry to her current role as President and Co-Founder of mend Labs, the Healing Company that is revolutionizing healthcare through Nutripharma-Powered Digital Wellness. Known as an innovator and change agent, Helene has held senior leadership roles including Global Head of Open Innovation at GlaxoSmithKline, Chief Innovation Officer at New Avon, VP of R&D at Nature’s Bounty (now the Bountiful Company), and Head of Global Clinical Supplies at Pfizer. In addition, Helene has served on the Board of Personal Care Products Council (PCPC) and is an award-winning product developer and subject matter expert on Innovation. Helene earned an Executive MBA from NYU Stern School of Business and a Bachelor of Engineering in Chemical Engineering with a minor in Chemistry from Manhattan College, where she has returned as an adjunct professor and to coach teams of entrepreneurs. She is a native New Yorker and amateur triathlete and relies on mend™ products for her performance and recovery.Links Supporting This Episode:MEND Website: CLICK HEREHelene Rutledge LinkedIn page: CLICK HEREMEND Twitter page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form:

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, Dr. David Klimstra, Founder and Chief Medical Officer at Paige, joins us to discuss how his company is driving a new era of diagnostics and precision treatment to improve the lives of cancer patients. While together, Dr. Klimstra shares how Paige has created decision-support diagnostic tools and a cloud-based platform for pathologists, enabling them to review digital slides and perform AI tasks on tissue samples. Additionally, Dr. Klimstra emphasizes the importance of prioritizing patient care in developing and using AI technologies and advises healthcare transformers to be patient and persistent in their pursuit of transforming healthcare. Join us for this timely and important conversation and to learn how Dr. Klimstra and the Paige team are transforming cancer diagnosis and treatment with artificial intelligence. Let’s go!Episode Highlights:How Paige uses AI assistance in cancer diagnosis and treatmentHow Paige creates decisions that support diagnostic tools and a platform for pathologistsDigital biomarkers for the prediction of mutations, survival, and recurrence/response to treatmentHow Paige received Breakthrough Status from FDA for prostate biopsy modelImportance of patient care in the development and use of AI technologiesAdvice for healthcare transformers to be patient and persistent  About our Guest: David Klimstra, M.D. is Founder and Chief Medical Officer at Paige, the first company to receive FDA approval for an AI product in digital pathology, Paige Prostate. He also serves as Medical Consultant at Memorial Sloan Kettering Cancer Center and Professor of Pathology and Laboratory Medicine at Weill Medical College of Cornell University. An internationally recognized expert on the pathology of tumors of the digestive system, pancreas, liver, and neuroendocrine system, he has published over 425 primary articles and his research focuses on the correlation of morphological and immunohistochemical features of tumors of the gastrointestinal tract, liver, biliary tree, and (most notably) pancreas with their clinical and molecular characteristics. Dr. Klimstra received his M.D. and completed a residency in anatomic pathology at Yale University, and he completed fellowship training in oncologic surgical pathology at Memorial Sloan Kettering Cancer Center. Links Supporting This Episode:Paige website: CLICK HEREPaige LinkedIn page: CLICK HEREPaige Twitter page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK...

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we are joined by Dr. Phil Wagner, CEO, and Founder of Sparta Science, a Movement Health Intelligence company dedicated to helping the world move better. While together, Dr. Wagner shares his journey in the health technology industry, the early beginnings of Sparta Science, and how his company is combining modern data science, clinical expertise, and epidemiological principles to fuel organization-wide movement health decisions. He also addresses common misconceptions about movement health intelligence and highlights the benefits of Sparta Science's technology for healthcare providers and patients.Additionally, Dr. Wagner emphasizes the importance of resilience, conviction, and flexibility in pursuing innovation in the healthcare industry.Join us for this exciting conversation as Dr. Wagner discusses how the Sparta Science team optimizes movement intelligence. Let’s go! Episode Highlights:Dr. Phil Wagner's journey in the health technology industryThe early beginnings of Sparta ScienceImportance of resilience in pursuing innovation in the healthcare industryInsights into the innovative solutions provided by Sparta ScienceAddressing common misconceptions about movement health intelligenceBenefits of Sparta Science's technology for healthcare providers and patientsThe positive impact of Sparta Science's movement health intelligence platform on compliance and patient outcomes  About our Guest: Dr. Phil Wagner is founder-CEO of Sparta Science, a physician and a strength coach whose own athletic career as a football and rugby player was cut short by a series of avoidable injuries. Dr. Wagner’s commitment to data-driven coaching and athlete development began as a strength coach for U.C. Berkeley and UCLA and as a professional rugby coach in New Zealand and Australia.Frustrated by the lack of evidence-based approaches in performance and injury prevention, Phil received his medical degree from USC focused on biomechanics. Phil’s passion for improving movement health and longevity through movement coupled with his medically-oriented human performance mindset inspired him to found Sparta Science, a human movement technology and data science company dedicated to helping the world move better.Links Supporting This Episode:Sparta Science Website: CLICK HEREDr. Phil Wagner LinkedIn page: CLICK HERESparta Science Twitter page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we are thrilled to welcome Dr. Ruchi Thanawala, Thoracic Surgeon and co-founder of FireFly Lab. While together, Dr. Thanawala shares her journey of becoming an entrepreneur after pursuing a career in surgery, and how FireFly Lab's Innovative Medical Acceleration Learning platform is helping doctors, residents, and surgeons master their surgical procedures through timely, actionable, individualized feedback and learning curves. We also address the advances of AI to power educational platforms and the way surgeons are trained, the game-changing impact of edtech platforms for future surgeons as well as advice for aspiring entrepreneurs looking to make a difference in the healthcare industry. Join us as Dr. Thanawala shares how she and the FireFly lab team are accelerating medical and surgical mastery. Let’s go! Episode Highlights:Dr. Thanawala’s journey of becoming an entrepreneur after her pursuit of being a surgeonWhy Dr. Thanawala started FireFly LabHow accelerated learning platforms make a difference in surgeon residents' education processWhat areas of education FireFly Lab is focused on todayDr. Thanawala’s advice for other aspiring entrepreneurs  About our Guest: Dr. Ruchi Thanawala, Thoracic Surgeon and co-founder of FireFly Lab, Dr. Thanawala was recruited to Oregon Health and Science University in late 2020. She joined the thoracic surgery faculty as an assistant professor, after completing her cardiothoracic surgery fellowship at the University of Iowa and her general surgery residency at the University of Massachusetts Medical School-Baystate Medical center. She also completed a Master of Science in Health Informatics from Northwestern University and a Surgical Education Research Fellowship from the Association of Surgical Education, becoming one of a very small number of thoracic surgeons informaticians with education research training in the U.S.Links Supporting This Episode:Firefly Lab website: CLICK HEREDr. Ruchi Thanawala LinkedIn page: CLICK HEREFirefly LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, Dr. Bob Booth, Chief Care Officer at TimelyCare joins us to discuss the importance of addressing mental health issues in college students and how their virtual care platform works with universities to provide care. While together, Dr. Booth shares his journey of joining TimelyCare, as well as the company's mission to improve the well-being of college students by making virtual medical and mental health care accessible anytime, anywhere. Additionally, Dr. Booth emphasizes the need for a population health approach and empowering students to take ownership of their own wellness. We also explore the future of the learning environment and mental health, as well as the importance of mental and behavioral health in our communities across the nation. Join us for an insightful conversation at the intersection of healthcare and higher education. Let’s go! Episode Highlights:The importance of doing hard things and embracing failure in healthcare innovationDr. Booth's journey to joining TimelyCareTimely MD's mission to provide virtual health and wellbeing solutions for higher education studentsThe importance of addressing mental health issues in college studentsHow TimelyMD works with universities to provide mental and behavioral health care through their platformThe future of higher education and mental healthThe importance of mental and behavioral health in communitiesAbout our Guest: Dr. Bob Booth brings extensive expertise in clinical administration and a unique combination of medical, mental health and higher education experiences that make him perfectly suited to lead the dynamic and innovative care team at TimelyCare.Most recently, Bob served as Regional Chief Medical Officer, VP of Physician Services at NorthStar Anesthesia, where he provided clinical and operational leadership across 43 hospital contracts from Texas to Montana. In this role, he led enterprise-wide strategy around developing and guiding clinical leaders to foster wellness in healthcare workers. He also played an integral role in shaping NorthStar’s approach to leadership development by addressing burnout, promoting well-being and building resiliency among providers.Prior to attending medical school at Texas Tech and completing his residency in Anesthesiology at Baylor Scott and White in Temple, Texas, he worked in student affairs. After earning his B.S. at Abilene Christian University, he worked as the Director of Living and Learning Communities for four years at ACU while pursuing his master’s degree in Counseling Psychology.Between his residence life and housing experience and completing practicum hours at the university’s on-campus counseling center, Bob has a deep and first-hand understanding of what college students are going through – from the continuum of homesickness to suicidal ideation.Bob’s heart for helping college and university students flourish physically, mentally, and spiritually aligns perfectly with TimelyMD’s vision to help students be well and thrive in all aspects of their lives.Links Supporting This Episode:TimelyMD website: CLICK HEREDr. Bob Booth LinkedIn page: CLICK HERETimelyMD Twitter page: